Abstract
Solenis, Ashland’s former water treatment chemicals business, is now in growth mode, says its chief executive officer, John Panichella. Six acquisitions in the past two years, investments in capacity, and new water chemistry monitoring technology are aimed at reviving a business that was pretty much on hold since 2008. Setting the scene for Solenis’s newfound emphasis on growth was its acquisition for $1.8 billion in August 2014 by Clayton, Dubilier & Rice (CD&R), a private equity firm that also owns the chemical distributor Univar and the industrial packaging firm Mauser Group. Whether that growth leads to an initial public offering of Solenis sometime down the road or its purchase by a strategic buyer really doesn’t matter, Panichella says. More important, he says, is doing right by a business that hadn’t made an acquisition since Ashland took it over in 2008 as part of its purchase of the specialty chemical maker
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
